跳至主要内容
临床试验/ACTRN12614000683639
ACTRN12614000683639已完成2 期

A randomised placebo controlled trial of nortriptyline for pain in knee osteoarthritis

Dr Ben Hudson0 个研究点目标入组 200 人开始时间: 2014年6月27日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Primary knee OA defined according to American College of Rheumatology (ACR) classification criteria (knee pain plus 3 of: age >50 years, stiffness <30 mins, crepitus, bony tenderness, bony enlargement, no palpable warmth).
  • 2. Pain severity of >=20 points on the Western Ontario and McMaster Universities (WOMAC) numerical rating scale (range 0 to 50 points) at the study knee.

排除标准

  • 01. Prior joint replacement surgery on the study knee
  • 02. Intra-articular steroid injection within the previous 3 months
  • 03. Secondary OA (OA due to inflammatory arthritis [eg gout, rheumatoid arthritis, juvenile arthritis], septic arthritis or trauma)
  • 04. Known hypersensitivity to nortriptyline or history of adverse reaction to any tricyclic antidepressant
  • 05. Current use of nortriptyline or other antidepressants, or amiodarone
  • 06. Within 6 months of myocardial infarction
  • 07. Heart block
  • 08. Postural hypotension
  • 09. Pregnancy
  • 10. Hyperthyroidism or phaeochromocytoma under current investigation or treatment
  • 11. History of epilepsy or other seizure
  • 12. History of bipolar disorder or manic episode
  • 13. History of increased intra-ocular pressure or history of angle-closure glaucoma
  • 14. Chronic constipation
  • 15. Urinary retention

研究者

发起方
Dr Ben Hudson

相似试验